Published January 28, 2025
| Version v1
Publication
Open
Pharmaceutical Industry Driven by Artificial Intelligence and Machine Learning
Files
30-43.pdf
Additional details
Identifiers
Related works
- Is documented by
- Publication: 3025-0129 (EISSN)
Dates
- Issued
-
2025-01-28
References
- [1] C. Selvaraj, I. Chandra, and S. K. Singh, "Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries," Mol. Divers., vol. 26, no. 3, pp. 1893–1913, 2022. [2] S. A. Kumar et al., "Machine learning and deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry," Future Med. Chem., vol. 14, no. 4, pp. 245–270, 2022. [3] A. B. Pazhayattil and G. Konyu-Fogel, "An empirical study to accelerate machine learning and artificial intelligence adoption in pharmaceutical manufacturing organizations," J. Generic Med., vol. 19, no. 2, pp. 81–91, 2023. [4] C. Sarkar et al., "Artificial intelligence and machine learning technology driven modern drug discovery and development," Int. J. Mol. Sci., vol. 24, no. 3, p. 2026, 2023. [5] S. Kolluri, J. Lin, R. Liu, Y. Zhang, and W. Zhang, "Machine learning and artificial intelligence in pharmaceutical research and development: a review," AAPS J., vol. 24, no. 1, p. 19, 2022.